AQUALIS:QoL of CLL Patients Treated With Acalabrutinib in France, Retrospective Study Based on Data From PLATON Database | MicrobiomeTrials← Back to trialsNCT06548152
AQUALIS:QoL of CLL Patients Treated With Acalabrutinib in France, Retrospective Study Based on Data From PLATON Database
RecruitingOBSERVATIONAL
Trial Details
Start: 2025-04-28Est. Completion: 2026-12-31
Enrollment target: 120 participants Locations- Research Site, Saint-Affrique, France
Other microbiome trials you might be interested in
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
This phase III trial compares early treatment with venetoclax and obinutuzumab versus delayed treatment with venetoclax …
Birmingham, United StatesEst. completion Oct 1, 2028
B-cell MalignancyMarginal Zone LymphomaFollicular LymphomaNon-Hodgkin LymphomaWaldenström MacroglobulinemiaChronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma
Mantle Cell Lymphoma
Diffuse Large B Cell Lymphoma
Study consists of two main parts to explore BGB-16673 recommended dosing, a Phase 1 monotherapy dose finding comprised o…
Birmingham, United StatesEst. completion Nov 2026
LeukemiaMantle Cell LymphomaMyelofibrosis
The goal of this clinical research study is to find the highest safe dose of RAD001 that can be given as a treatment for…
Houston, United StatesCompleted Sep 2006